Aonong Group(SH:603363) Shang Hai Zheng Quan Bao·2025-12-30 22:14Core Viewpoint - The report outlines the changes in shareholding structure of Fujian Aonong Biological Technology Group Co., Ltd. due to the expiration of the "Joint Action Agreement" among the information disclosing parties, leading to the individual calculation of their respective shareholdings [1][5]. Group 1: Shareholding Changes - The information disclosing parties collectively held 208 million shares, accounting for 7.99% of the total share capital before the expiration of the agreement [7]. - After the expiration of the agreement on December 27, 2025, the shareholdings will be calculated separately: China Foreign Economic and Trade Trust holds 65 million shares (2.4972%), Xiamen International Trust holds 123 million shares (4.7254%), and Beijing Yawen holds 20 million shares (0.7684%) [8]. - Following the expiration, none of the information disclosing parties will be considered as shareholders holding more than 5% of the company [8]. Group 2: Purpose of the Equity Change - The purpose of the equity change is due to the termination of the "Joint Action Agreement," which does not involve any change in the number of shares held by the information disclosing parties [5]. - The parties plan to reduce their holdings in Aonong Biological shares within the next 12 months based on their actual circumstances after the termination of the joint action relationship [5][6]. Group 3: Compliance and Disclosure - The report confirms that the information disclosing parties have obtained necessary authorizations and approvals for the report, ensuring compliance with relevant laws and regulations [2]. - There are no restrictions on the rights associated with the shares held by the information disclosing parties as of the report's signing date [9].